Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisor...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	M. Fehlings, Y. Simoni, H. L. Penny, E. Becht, C. Y. Loh, M. M. Gubin, J. P. Ward, S. C. Wong, R. D. Schreiber, E. W. Newell
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2018
Sujets:	Science Q
Accès en ligne:	https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf56
record_format	dspace
spelling	oai:doaj.org-article:f7dba004c3344d4cbafb00588e41bf562021-12-02T14:39:26ZAuthor Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells10.1038/s41467-018-05468-y2041-1723https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf562018-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05468-yhttps://doaj.org/toc/2041-1723The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.M. FehlingsY. SimoniH. L. PennyE. BechtC. Y. LohM. M. GubinJ. P. WardS. C. WongR. D. SchreiberE. W. NewellNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
description	The original version of this Article omitted a declaration from the competing interests statement, which should have included the following: ‘R.D.S. is a cofounder, stock holder, and scientific advisory board member of Jounce Therapeutics and Neon Therapeutics, and a member of the scientific advisory boards of BioLegend, Constellation, Lytix, and NGM. He also received research funding from Janssen and Agios.’. This has now been corrected in both the PDF and HTML versions of the Article.
format	article
author	M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell
author_facet	M. Fehlings Y. Simoni H. L. Penny E. Becht C. Y. Loh M. M. Gubin J. P. Ward S. C. Wong R. D. Schreiber E. W. Newell
author_sort	M. Fehlings
title	Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_short	Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full	Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_fullStr	Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_full_unstemmed	Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
title_sort	author correction: checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific cd8+ t cells
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/f7dba004c3344d4cbafb00588e41bf56
work_keys_str_mv	AT mfehlings authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ysimoni authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT hlpenny authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ebecht authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT cyloh authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT mmgubin authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT jpward authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT scwong authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT rdschreiber authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells AT ewnewell authorcorrectioncheckpointblockadeimmunotherapyreshapesthehighdimensionalphenotypicheterogeneityofmurineintratumouralneoantigenspecificcd8tcells
_version_	1718390631056801792

Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

Documents similaires